Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.
Vesicular stomatitis virus (VSV) causes acute infection of the central nervous system (CNS) when intranasally applied. We have examined cellular inflammatory changes in the CNS following VSV infection. As early as 1 day postinfection (p.i.), astrocytes were activated in the olfactory bulb (OB). This was followed by activation of microglia, first observed in the OB at day 3 p.i. Expression of inducible nitric oxide synthase was observed in activated microglia in the OB at day 3 p.i., and increased inducible nitric oxide synthase expression coincided with decreased virus titers in tissue homogenates. Expression of major histocompatibility complex (MHC) class I molecules on astrocytes and microglial, endothelial, and ependymal cells was also rapidly induced and followed by induced expression of MHC class II molecules on astrocytes and microglial and endothelial cells. Consistent with the pattern of viral dissemination, MHC molecules were expressed temporally from the rostral-to-caudal direction. Infiltration of CD8+ cells was observed as early as 1 day p.i. in the OB. CD4+ cells were detected in the OB at day 4 p.i. Increasing T-cell infiltration coincided with decreased virus titers. In contrast, B-cell infiltration of the CNS was not detected until day 14 p.i., after the virus was cleared and mice were showing behavioral signs of recovery. Breakdown of the blood-brain barrier was detected beginning at day 6 p.i., was most severe at day 8 p.i., and was followed by full recovery. Collectively, these data show that both innate immunity (production of nitric oxide) and acquired immunity (expression of MHC molecules and T-cell infiltration) are activated following VSV infection in the CNS.
Bi
Z
Z
Department of Biology, New York University, New York 10003-6688, USA.
Barna
M
M
Komatsu
T
T
Reiss
C S
CS
D000594:Amino Acid Oxidoreductases / Q000096:biosynthesis; D000818:Animals; D001253:Astrocytes / Q000276:immunology / Q000502:physiology; D001812:Blood-Brain Barrier; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D002493:Central Nervous System Diseases / Q000276:immunology / Q000503:physiopathology / Q000821:virology*; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis; D007109:Immunity; D007113:Immunity, Innate; D007249:Inflammation; D008285:Major Histocompatibility Complex; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D017628:Microglia / Q000276:immunology / Q000502:physiology; D019001:Nitric Oxide Synthase; D018353:Rhabdoviridae Infections / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013997:Time Factors; D014721:Vesicular stomatitis Indiana virus
D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases